Discern Report is the fastest growing America First news aggregator in the nation.
Reading Time: 3 minutes
Charlotte, NC — On Friday, mainstream media outlets were pushing the story about Pfizer’s antiviral medication Paxlovid. Pfizer shared that the pill cut the risk of serious COVID-19 cases by 89%. The report sounds encouraging but is misleading entirely.
First of all, the study by Pfizer was discontinued very early. According to the AP report , only 775 adults were studied as part of the Pfizer report. The AP also shared, “an independent group of medical experts monitoring the trial recommended stopping it early, standard procedure when interim results show such a clear benefit.”
But that’s not the case with typical drug trials. Typically the trials consist of much more research and investigation into the safety and efficacy of the medication. Instead, Pfizer shared very little data regarding the side effects and risks of the medication.
The second thing that the mainstream media wants to bury is the fact that this medication was administered in coordination with another antiviral medication called ritonavir. Ritonavir is an antiviral that is typically given to HIV patients.
Mainstream media outlets railed against the possible use of antiviral medications for the treatment of COVID in the past. They have been critical of the consideration of […]
Read the whole story at thelibertyloft.com
Covid variant BA.5 is spreading. It appears milder but much more contagious and evades natural immunity. Best to boost your immune system with new Z-Dtox and Z-Stack nutraceuticals from our dear friend, the late Dr. Vladimir Zelenko.